| Name | Title | Contact Details |
|---|---|---|
Rob Sitze |
Virtual Chief Information Officer | Profile |
John Stephens |
Chief Information Security Officer | Profile |
BuildSourced is an innovative technology company that provides industrial asset tracking and analytics for increased control and maximum efficiency of physical assets. Industrial clients in logistics, construction, transportation and utilities rely on products, solutions and services from BuildSourced in the areas of physical asset management and location intelligence. BuildSourced`s online public marketplace enables members to buy, sell rent or share their equipment and materials, creating a virtual shared economy for businesses across industries.
Innovative e-crime intelligence company helping the worlds largest corporations reduce fraud, cyber breaches, and other electronic crimes.
Based in Austin, Texas, with a presence in Washington, DC, Pullbutton is helping drive a massive paradigm shift in the future of online commerce, and making it better by giving people a more efficient option. Search Engines, classified sites/apps, online marketplaces, and online commerce in general, hasn`t really innovated in over 15 years. Craigslist copycats and niche marketplaces are running rampant, and search engines are hardly efficient enough for todays busy consumer. Addressing The Future of Search at the most fundamental level, Pullbutton re-thinks how people buy, sell and exchange information online. Pullbutton is a single, universal, buying and selling ecosystem, that automates the connection between supply and demand. Pullbutton enhances communication capabilities and creates a tightly-knit, online commerce community by pulling together buyers and sellers from within the app, and throughout the web via strategic APIs.
Pequeña tienda online de cacharreo electrónico donde se apuesta por productos Made in Spain.
Immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. Our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. This proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. We then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.